FutureChem Co.,Ltd (KOSDAQ:220100) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Apr 29
South Korean (KOSPI) Clinical Research and Equipment Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies33
- 7D0.6%
- 3M-2.8%
- 1Y1.4%
- YTDn/a
In the last week, the Clinical Research and Equipment industry is flat overall, with Curiox Biosystems standing out by going down 3.1%. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 May 2024 | ₩61.7t | ₩4.4t | ₩635.1b | 20x | 97.2x | 14.1x |
| Fri, 05 Apr 2024 | ₩64.6t | ₩4.7t | ₩656.9b | 19x | 98.4x | 13.8x |
| Sun, 03 Mar 2024 | ₩60.7t | ₩4.6t | ₩635.2b | 34.6x | 95.6x | 13.1x |
| Tue, 30 Jan 2024 | ₩62.6t | ₩4.5t | ₩714.4b | 34.3x | 87.7x | 13.8x |
| Thu, 28 Dec 2023 | ₩58.2t | ₩4.5t | ₩721.5b | 32.6x | 80.7x | 12.8x |
| Sat, 25 Nov 2023 | ₩56.1t | ₩4.6t | ₩742.0b | 21.9x | 75.6x | 12.3x |
| Mon, 23 Oct 2023 | ₩55.3t | ₩4.4t | ₩660.9b | 27.1x | 83.7x | 12.6x |
| Wed, 20 Sep 2023 | ₩58.2t | ₩4.4t | ₩660.9b | 30.7x | 88.1x | 13.2x |
| Fri, 18 Aug 2023 | ₩60.7t | ₩4.2t | ₩673.4b | 28.2x | 90.2x | 14.5x |
| Sun, 16 Jul 2023 | ₩58.0t | ₩4.2t | ₩673.4b | 29.1x | 86.2x | 13.8x |
| Tue, 13 Jun 2023 | ₩61.8t | ₩4.2t | ₩666.5b | 30.4x | 92.7x | 14.5x |
| Thu, 11 May 2023 | ₩61.1t | ₩4.1t | ₩626.3b | 27.6x | 97.5x | 14.9x |
| Sat, 08 Apr 2023 | ₩62.3t | ₩4.1t | ₩626.3b | 28.9x | 99.4x | 15.2x |
| Mon, 06 Mar 2023 | ₩61.6t | ₩3.5t | ₩427.8b | 21.5x | 144.1x | 17.7x |
| Wed, 01 Feb 2023 | ₩62.0t | ₩3.5t | ₩426.6b | 20.1x | 145.4x | 17.8x |
| Fri, 30 Dec 2022 | ₩64.1t | ₩3.4t | ₩428.7b | 21.3x | 149.6x | 18.7x |
| Sun, 27 Nov 2022 | ₩69.8t | ₩3.4t | ₩441.6b | 21.9x | 158x | 20.5x |
| Tue, 25 Oct 2022 | ₩65.6t | ₩3.0t | ₩448.5b | 23.1x | 146.2x | 22x |
| Thu, 22 Sep 2022 | ₩61.6t | ₩3.0t | ₩448.5b | 26.1x | 137.4x | 20.6x |
| Sat, 20 Aug 2022 | ₩68.5t | ₩2.7t | ₩454.7b | 28.1x | 150.6x | 25.2x |
| Mon, 18 Jul 2022 | ₩64.9t | ₩2.7t | ₩454.7b | 28.7x | 142.8x | 23.9x |
| Wed, 15 Jun 2022 | ₩63.3t | ₩2.7t | ₩454.7b | 25x | 139.1x | 23.3x |
| Fri, 13 May 2022 | ₩62.9t | ₩2.4t | ₩379.4b | 22.7x | 165.7x | 25.9x |
| Sun, 10 Apr 2022 | ₩60.2t | ₩2.4t | ₩379.4b | 25x | 158.8x | 24.8x |
| Tue, 08 Mar 2022 | ₩57.0t | ₩2.4t | ₩408.2b | 25.2x | 139.5x | 24.2x |
| Thu, 03 Feb 2022 | ₩55.6t | ₩2.3t | ₩412.7b | 23.7x | 134.7x | 23.7x |
| Sat, 01 Jan 2022 | ₩67.8t | ₩2.3t | ₩412.7b | 28.3x | 164.4x | 28.9x |
| Mon, 29 Nov 2021 | ₩64.9t | ₩2.3t | ₩390.6b | 26.2x | 166x | 28x |
| Wed, 27 Oct 2021 | ₩65.2t | ₩2.1t | ₩329.9b | 27.5x | 197.6x | 30.3x |
| Fri, 24 Sep 2021 | ₩68.7t | ₩2.1t | ₩329.9b | 30.7x | 208.1x | 32x |
| Sun, 22 Aug 2021 | ₩73.0t | ₩2.2t | ₩336.8b | 32.9x | 216.7x | 33x |
| Fri, 09 Jul 2021 | ₩64.5t | ₩2.2t | ₩336.8b | 37.9x | 191.6x | 29.2x |
Price to Earnings Ratio
259.8x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 95.6x which is lower than its 3-year average PE of 136x.
- The 3-year average PS ratio of 20.7x is higher than the industry's current PS ratio of 13.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 37% per year over the last three years.
- Revenues for these companies have grown 28% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Clinical Research and Equipment compare with similar industries?
| KR Market | 1.43% | |
| Healthcare | 0.54% | |
| Life Sciences | 0.56% | |
| Clinical Research and Equipment | 0.56% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A207940 Samsung BiologicsLtd | ₩793.00k | 1.5% +₩854.1b | 1.7% | PE65.8x | |
| A087010 Peptron | ₩30.40k | 4.8% +₩28.9b | 303.7% | PS187.6x | |
| A223250 DreamCIS | ₩4.01k | 33.2% +₩23.1b | 25.0% | PE24.7x | |
| A383930 DT&CRO | ₩7.90k | 18.6% +₩15.8b | 31.7% | n/a | |
| A141080 LigaChem Biosciences | ₩68.40k | 0.4% +₩10.8b | 70.1% | PS72x |
